Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-03 Sale |
2025-03-04 4:15 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
2,275 | $35.54 | $80,854 | 110,572 (Direct) |
View |
2024-09-26 Sale |
2024-09-30 4:15 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
2,542 | $49.03 | $124,634 | 27,630 (Direct) |
View |
2024-03-05 Sale |
2024-03-05 4:18 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
672 | $32.57 | $21,887 | 95,840 (Direct) |
View |
2024-01-24 Sale |
2024-01-24 4:23 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
1,886 | $21.64 | $40,813 | 13,069 (Direct) |
View |
2023-09-28 Sale |
2023-09-28 4:02 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
2,179 | $24.79 | $54,017 | 24,520 (Direct) |
View |
2023-06-30 Sale |
2023-06-30 4:03 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
1,597 | $28.36 | $45,291 | 9,163 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-01 Option Award |
2025-03-04 4:15 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
71,410 | $0 | 110,572 (Direct) |
View |
2025-03-01 Exercise |
2025-03-04 4:15 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
7,667 | $0 | 110,572 (Direct) |
View |
2024-09-26 Exercise |
2024-09-30 4:15 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
7,473 | $0 | 27,630 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 4:18 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
77,000 | $0 | 95,840 (Direct) |
View |
2024-03-01 Exercise |
2024-03-05 4:18 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
2,000 | $0 | 95,840 (Direct) |
View |
2024-01-20 Exercise |
2024-01-24 4:23 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
5,380 | $0 | 13,069 (Direct) |
View |
2023-09-26 Exercise |
2023-09-28 4:02 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
7,472 | $0 | 24,520 (Direct) |
View |
2023-06-28 Exercise |
2023-06-30 4:03 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
5,380 | $0 | 9,163 (Direct) |
View |
2023-03-01 Option Award |
2023-03-03 4:07 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
28,000 | $0 | 28,000 (Direct) |
View |
2022-09-26 Option Award |
2022-09-28 4:10 pm |
N/A 2032-09-26 |
AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer |
140,807 | $0 | 140,807 (Direct) |
View |
2022-03-01 Option Award |
2022-03-03 6:05 pm |
N/A 2032-03-01 |
LogicBio Therapeutics Inc. | LOGC | Jones Cecilia Chief Financial Officer |
112,000 | $0 | 112,000 (Direct) |
View |
2022-01-11 Exercise |
2022-01-13 6:36 pm |
N/A N/A |
LogicBio Therapeutics Inc. | LOGC | Jones Cecilia Chief Financial Officer |
5,939 | $0 | 3,764 (Direct) |
View |
2022-01-12 Tax Withholding |
2022-01-13 6:36 pm |
N/A N/A |
LogicBio Therapeutics Inc. | LOGC | Jones Cecilia Chief Financial Officer |
2,175 | $2.01 | 3,764 (Direct) |
View |
2021-02-23 Option Award |
2021-02-25 7:00 pm |
N/A 2031-02-23 |
LogicBio Therapeutics Inc. | LOGC | Jones Cecilia Chief Financial Officer |
78,000 | $0 | 78,000 (Direct) |
View |
2021-01-11 Option Award |
2021-01-13 7:10 pm |
N/A 2031-01-11 |
LogicBio Therapeutics Inc. | LOGC | Jones Cecilia Chief Financial Officer |
200,939 | $0 | 200,939 (Direct) |
View |